Zenicor Medical Systems AB
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection; and Zenicor View, a web-based system solution for all types of arrhythmia investigations. It also provide… Read more
Zenicor Medical Systems AB (ZENI) - Total Assets
Latest total assets as of September 2025: Skr69.89 Million SEK
Based on the latest financial reports, Zenicor Medical Systems AB (ZENI) holds total assets worth Skr69.89 Million SEK as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zenicor Medical Systems AB - Total Assets Trend (2020–2024)
This chart illustrates how Zenicor Medical Systems AB’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zenicor Medical Systems AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Zenicor Medical Systems AB's total assets of Skr69.89 Million consist of 37.6% current assets and 62.4% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 1.4% |
| Accounts Receivable | Skr780.54K | 1.2% |
| Inventory | Skr3.60 Million | 5.7% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr35.02 Million | 55.4% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Zenicor Medical Systems AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zenicor Medical Systems AB's current assets represent 37.6% of total assets in 2024, a decrease from 58.9% in 2020.
- Cash Position: Cash and equivalents constituted 1.4% of total assets in 2024, down from 3.6% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 55.0% of total assets, an increase from 40.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 55.4% of total assets.
Zenicor Medical Systems AB Competitors by Total Assets
Key competitors of Zenicor Medical Systems AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Zenicor Medical Systems AB - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Zenicor Medical Systems AB generates 0.40x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Zenicor Medical Systems AB is currently not profitable relative to its asset base.
Zenicor Medical Systems AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.39 | 1.32 | 1.08 |
| Quick Ratio | 1.18 | 1.08 | 0.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr8.69 Million | Skr 5.51 Million | Skr 1.11 Million |
Zenicor Medical Systems AB - Advanced Valuation Insights
This section examines the relationship between Zenicor Medical Systems AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.64 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 5.0% |
| Total Assets | Skr63.23 Million |
| Market Capitalization | $1.13 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zenicor Medical Systems AB's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zenicor Medical Systems AB's assets grew by 5.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zenicor Medical Systems AB (2020–2024)
The table below shows the annual total assets of Zenicor Medical Systems AB from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr63.23 Million | +5.01% |
| 2023-12-31 | Skr60.22 Million | +31.12% |
| 2022-12-31 | Skr45.92 Million | +13.59% |
| 2021-12-31 | Skr40.43 Million | +22.61% |
| 2020-12-31 | Skr32.97 Million | -- |